Although Japan has a reputation as a difficult market for new medical products to enter, the government and several public/private initiatives are making ground-breaking efforts to change that image. Several initiatives--some modeled after US Food & Drug Administration practices--will be launched in 2009. These changes, as well as others made in 2008, already are cutting into the drawn-out review times that manufacturers historically have had to face as a normal part of doing business in the country.
by Robert Neil
Attention medical device manufacturers: Japan is calling. Although the country has a reputation as a difficult market for new medical...
Join thousands of industry professionals who rely on Medtech Insight for daily insights
Already a subscriber?
A recent JAMA column called for the US FDA to create an online database of medical device labeling, arguing that the move would increase transparency and help researchers, among other benefits. Medtech Insight discussed the idea with the paper’s lead author.
A recent FDA warning letter claims a Boston firm that specializes in wearable technology marketed a blood pressure device without agency approval. The company rejects the assertion and says the agency is out of step with federal law.
US Medicare has proposed national coverage of renal denervation for patients with uncontrolled hypertension. The treatment is seeing other advances as well, with Medtronic piloting a longer catheter and a multi-organ approach and a blood test to identify the best candidates fresh on the
The US House of Representatives passes legislation requiring manufacturers of non-flushable wet wipes to label products as ‘non-flushable," a move endorsed by the Personal Care Products Council.
Medicare beneficiaries with tricuspid regurgitation will now have access to an innovative treatment from Abbott that offers a minimally invasive alternative to open-heart surgery.
MedTech Europe wants the EU to continue its commitment to reach a negotiated tariff solution with the US and measured restraint amid escalating trade tensions.
A surgeon at Ochsner Health in New Orleans was able to successfully remove a rare and dangerous tumor from a patient’s spine using cutting-edge technology that would have otherwise made the procedure too risky.
